Trial
NCT02413047
Evaluate if Response to Infliximab or Adalimumab May be Regained With an Immunomodulator
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Indiana University
Collaborators
—
Condition
Inflammatory Bowel Disease
Intervention
Azathioprine
Why stopped
physician decision to stop study early due to low enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-04